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Wound healing mediators in dermal and joint tissues showing their source and major effects on cellular responses




EGF SY[133]; OA SF[134] Chondrocyte proliferation; ion transport, decreased
matrix production
P,M,F Epithelialization
FGF-2 SY[135e137]; AT[138]; OP[137]; OA SF[139e142] Anti-apoptotic; prochondrogenic M,EP,END,F Angiogenesis
Granulation tissue
ECM production
TGFb1 CA[143]; SY[144]; OP[137, 145]; OA SF[47, 48] Pro-catabolic (MMP-13); chondrocyte hypertrophy P,M,EP,END,F Epithelialization,
Granulation Tissue
Fibroplasia
BMPs SY[152]; CA[146e148]; BO[149, 150]; OA SF[151] Prochondrogenic; Osteophytes SC Hairfollicle formation





VEGF CA[155e159,163]; SY[158e161], AT[138]; OA SF[47, 162] Delays reparative responses in meniscus and CA P,N,M,END,F Angiogenesis
IL1b CA[143]; SY[180]; post ACLT SF[164e167]; OA SF
[48, 167e170]
CA and meniscal matrix degradation N,M,EP Inﬂammation
Epithelialization
IL6 CA[171, 172]; AT[138, 173]; PC[174]; Post ACL SF
[164, 175]; OA SF[48, 169]
CA matrix degradation N,M,EP Inﬂammation
Epithelialization
TNFa CA[143]; SY[176]; AT[138]; Post ACLT SF[167,170,175,
177,178]; OA SF[48,168,169].
CA matrix degradation N,M,EP Inﬂammation
Epithelialization
Abbreviations: ACLT: Anterior cruciate ligament tear; AT: Adipose tissue; OP: Osteophyte; PC: Plasma Cells; END: endothelial cells; EP: epithelial cells; F: Fibroblasts;
M: Macrophages; N: Neutrophils; P: Platelets.Missing References
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